Nicolas Thurin 1, 2, Régis Lassalle 1, Patrick Blin 1, Marine Pénichon 1, Martijn Schuemie 3, 4, Joshua J Gagne 5, Jeremy A. Rassen 6, Jacques Benichou 7, 8, Alain Weill 9, Cécile Droz-Perroteau 1, Nicholas Moore1, 2

1 – Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, Bordeaux, France; 2 – INSERM U1219; 3 – Epidemiology Analytics, Janssen Research and Development, Titusville, NJ, USA, 4 – OHDSI, New York, NY, USA; 5 – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA; 6 – Aetion, Inc., New York, NY, USA; 7 – Department of Biostatistics and Clinical Research, Rouen University Hospital Rouen, France; 8 – INSERM U1181; 9 – Caisse Nationale de l’Assurance Maladie, Paris, France

Files

Abstract
Poster PDF
ALPACONE Project Paper (Pharmacoepidemiology & Drug Safety)